recast-jats-buildd8e1462159jitcJ Immunother CancerjitcJournal for ImmunoTherapy of CancerJ Immunother CancerJ Immunother Cancer2051-1426BMJ Publishing Group Ltdjitc-2019-000381corr110.1136/jitc-2019-000381corr132938626/jitc/8/2/e000381corr1.atomCorrectionOpen accessSpecial collectionsOpen accessCorrection: Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study 92020169202029620202962020169202082e000381corr1© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.2020http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.special-featureunlocked

Bai X, Wu D, Ma S, et al. Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study. J Immunothera Cancer 2020;8:e000381. doi: 10.1136/jitc-2019-000381

Since the online publication of this article, the authors have noticed that the word ‘study’ in the title was missing the last letter 'y'. The correct title is ‘Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study’ and has been updated in the article. Additionally, the tables were in the incorrect order in the article.